Cargando…

South African medicinal plants displaying angiotensin-converting enzyme inhibition: Potential use in the management of preeclampsia

In resource-limited settings, such as South Africa, hypertensive disorders of pregnancy such as preeclampsia, is the most common direct cause of maternal deaths. Current management strategies of preeclampsia primarily involve the use of pharmaceutical drugs, which are frequently associated with unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Reddy, Rebecca, Baijnath, Sooraj, Moodley, Roshila, Moodley, Jagidesa, Naicker, Thajasvarie, Govender, Nalini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178479/
https://www.ncbi.nlm.nih.gov/pubmed/35675745
http://dx.doi.org/10.1016/j.jaim.2022.100562
_version_ 1784723070975475712
author Reddy, Rebecca
Baijnath, Sooraj
Moodley, Roshila
Moodley, Jagidesa
Naicker, Thajasvarie
Govender, Nalini
author_facet Reddy, Rebecca
Baijnath, Sooraj
Moodley, Roshila
Moodley, Jagidesa
Naicker, Thajasvarie
Govender, Nalini
author_sort Reddy, Rebecca
collection PubMed
description In resource-limited settings, such as South Africa, hypertensive disorders of pregnancy such as preeclampsia, is the most common direct cause of maternal deaths. Current management strategies of preeclampsia primarily involve the use of pharmaceutical drugs, which are frequently associated with undesirable side-effects. Moreover, these drugs are often not easily accessible due to financial and economic constraints. Consequently, many patients rely on traditional medicine obtained from medicinal plants to manage health-related conditions. Angiotensin-converting enzyme inhibitors are widely used drugs for the management of preeclampsia. This narrative review aims to highlight the use of indigenous medicinal plants from South Africa with Angiotensin-converting enzyme inhibitory activity whilst also evaluating their potential use in the treatment of hypertension in pregnancy. This information will influence traditional healers and sangomas in their patient management. Furthermore, the antihypertensive potential of these plants will be unraveled thus facilitating the development of new naturally occurring pharmaceutical products to reduce maternal and neonatal mortality and morbidity.
format Online
Article
Text
id pubmed-9178479
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-91784792022-06-10 South African medicinal plants displaying angiotensin-converting enzyme inhibition: Potential use in the management of preeclampsia Reddy, Rebecca Baijnath, Sooraj Moodley, Roshila Moodley, Jagidesa Naicker, Thajasvarie Govender, Nalini J Ayurveda Integr Med Review Article In resource-limited settings, such as South Africa, hypertensive disorders of pregnancy such as preeclampsia, is the most common direct cause of maternal deaths. Current management strategies of preeclampsia primarily involve the use of pharmaceutical drugs, which are frequently associated with undesirable side-effects. Moreover, these drugs are often not easily accessible due to financial and economic constraints. Consequently, many patients rely on traditional medicine obtained from medicinal plants to manage health-related conditions. Angiotensin-converting enzyme inhibitors are widely used drugs for the management of preeclampsia. This narrative review aims to highlight the use of indigenous medicinal plants from South Africa with Angiotensin-converting enzyme inhibitory activity whilst also evaluating their potential use in the treatment of hypertension in pregnancy. This information will influence traditional healers and sangomas in their patient management. Furthermore, the antihypertensive potential of these plants will be unraveled thus facilitating the development of new naturally occurring pharmaceutical products to reduce maternal and neonatal mortality and morbidity. Elsevier 2022 2022-06-05 /pmc/articles/PMC9178479/ /pubmed/35675745 http://dx.doi.org/10.1016/j.jaim.2022.100562 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review Article
Reddy, Rebecca
Baijnath, Sooraj
Moodley, Roshila
Moodley, Jagidesa
Naicker, Thajasvarie
Govender, Nalini
South African medicinal plants displaying angiotensin-converting enzyme inhibition: Potential use in the management of preeclampsia
title South African medicinal plants displaying angiotensin-converting enzyme inhibition: Potential use in the management of preeclampsia
title_full South African medicinal plants displaying angiotensin-converting enzyme inhibition: Potential use in the management of preeclampsia
title_fullStr South African medicinal plants displaying angiotensin-converting enzyme inhibition: Potential use in the management of preeclampsia
title_full_unstemmed South African medicinal plants displaying angiotensin-converting enzyme inhibition: Potential use in the management of preeclampsia
title_short South African medicinal plants displaying angiotensin-converting enzyme inhibition: Potential use in the management of preeclampsia
title_sort south african medicinal plants displaying angiotensin-converting enzyme inhibition: potential use in the management of preeclampsia
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178479/
https://www.ncbi.nlm.nih.gov/pubmed/35675745
http://dx.doi.org/10.1016/j.jaim.2022.100562
work_keys_str_mv AT reddyrebecca southafricanmedicinalplantsdisplayingangiotensinconvertingenzymeinhibitionpotentialuseinthemanagementofpreeclampsia
AT baijnathsooraj southafricanmedicinalplantsdisplayingangiotensinconvertingenzymeinhibitionpotentialuseinthemanagementofpreeclampsia
AT moodleyroshila southafricanmedicinalplantsdisplayingangiotensinconvertingenzymeinhibitionpotentialuseinthemanagementofpreeclampsia
AT moodleyjagidesa southafricanmedicinalplantsdisplayingangiotensinconvertingenzymeinhibitionpotentialuseinthemanagementofpreeclampsia
AT naickerthajasvarie southafricanmedicinalplantsdisplayingangiotensinconvertingenzymeinhibitionpotentialuseinthemanagementofpreeclampsia
AT govendernalini southafricanmedicinalplantsdisplayingangiotensinconvertingenzymeinhibitionpotentialuseinthemanagementofpreeclampsia